Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35
about
Metabolic Surgery for Type 2 Diabetes Mellitus: Experience from AsiaBaseline of visceral fat area and decreased body weight correlate with improved pulmonary function after Roux-en-Y gastric bypass in Chinese obese patients with BMI 28-35 kg/m² and type 2 diabetes: a 6-month follow-upObesity and the need for bariatric surgery in Pakistan.Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American SocGastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus.Decreased serum CA19-9 is associated with improvement of insulin resistance and metabolic control in patients with obesity and type 2 diabetes after Roux-en-Y gastric bypass.Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis.Gastrointestinal intervention ameliorates high blood pressure through antagonizing overdrive of the sympathetic nerve in hypertensive patients and rats.A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI ≤ 35 kg/m2 undergoing Roux-en-Y gastric bypass.Roux-en-Y gastric bypass for Chinese type 2 diabetes mellitus patients with a BMI < 28 kg/m(2): a multi-institutional studyBariatric surgery: prevalence, predictors, and mechanisms of diabetes remission.Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2)The Effectiveness of Bariatric Surgery for Chinese Obesity in 2 Years: A Meta-Analysis and Systematic Review.Evaluation of current eligibility criteria for bariatric surgery: diabetes prevention and risk factor changes in the Swedish obese subjects (SOS) study.Changes in Adipokines following Laparoscopic Roux-en-Y Gastric Bypass Surgery in Chinese Individuals with Type 2 Diabetes Mellitus and BMI of 22-30 kg·m(-2.).Preoperative use of incretins is associated with increased diabetes remission after RYGB surgery among patients taking insulin: a retrospective cohort analysis.Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity.Evaluation of Weight Loss Failure, Medical Outcomes, and Personal Experiences after Roux-en-Y Gastric Bypass: A Critical Analysis.Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study.Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index < 35 kg/m2.Impact of gastrointestinal surgery on cardiometabolic risk.Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes.Efficacy of metabolic surgery on HbA1c decrease in type 2 diabetes mellitus patients with BMI <35 kg/m2--a review.Bariatric surgery in class I obesity : a Position Statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).Predicting remission of diabetes after RYGB surgery following intensive management to optimize preoperative glucose control.Impact of roux-en Y gastric bypass surgery on prognostic factors of type 2 diabetes mellitus: meta-analysis and systematic review.Gap Between Evidence and Patient Access: Policy Implications for Bariatric and Metabolic Surgery in the Treatment of Obesity and its Complications.Comparative Study Between Laparoscopic Adjustable Gastric Banded Plication and Sleeve Gastrectomy in Moderate Obesity--2 Year Results.Serum stearic acid/palmitic acid ratio as a potential predictor of diabetes remission after Roux-en-Y gastric bypass in obesity.The effect of long Roux-en-Y gastrojejunostomy in gastric cancer patients with type 2 diabetes and body mass index < 35 kg/m(2): preliminary results.The relationship between volume and outcome after bariatric surgery: a nationwide study in Taiwan.Effects of Laparoscopic Roux-en-Y Gastric Bypass for Type 2 Diabetes Mellitus: Comparison of BMI > 30 and < 30 kg/m2.Gastric bypass in Type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomes.Improvement of type 2 diabetes mellitus (T2DM) after bariatric surgery--who fails in the early postoperative course?Do Bariatric Surgery-Related Type 2 Diabetes Remission Predictors Add Clinical Value? A Study on Asian Indian Obese Diabetics.Effect of Roux-en-Y Gastric Bypass on Remission of T2D: Medium-Term Follow-up in Chinese Patients with Different BMI Obesity Class.Loop Duodenojejunal Bypass with Sleeve Gastrectomy: Comparative Study with Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients with a BMI <35 kg/m(2), First Year Results.A Comparative Study of the Effect of Gastric Bypass, Sleeve Gastrectomy, and Duodenal-Jejunal Bypass on Type-2 Diabetes in non-Obese Rats.Effects of gastric bypass on type 2 diabetes in patients with BMI 30 to 35.Remission of type 2 diabetes after omega loop gastric bypass for morbid obesity.
P2860
Q28069918-58704693-C417-4211-A2A5-5D744C78D759Q28396019-439A3F5A-827B-4B79-B08C-B27931B50B73Q30351930-69335009-08AF-495F-9A6E-9F361BBE87FDQ34075016-C36D2935-5908-41F8-9761-986F522A05E2Q34366918-0E9544DD-0A19-436F-A9AE-4D04001725C5Q34523725-40467025-B3FF-4C4C-8A2B-15D40998E7BCQ34978560-4DE49D42-880B-4256-A1A5-CDCFD2BE36FDQ35070635-6C5E2C05-CA79-4842-812A-C4D736BC5AD0Q35232361-DA14671D-F736-435D-BA3C-02DBE54CACDDQ35310232-F265762C-0C59-4C9C-A05F-C1E584AFF352Q35564937-39E969AB-5438-4F18-A2A9-5708F8E11134Q36031995-0F00B0A6-4156-49D9-A824-1CCB9B2B5F44Q36180531-9E447E22-4E1B-4ADE-9AE8-BF85B6C6B702Q36782693-79DFA067-8728-43EA-BDCF-9EA97E43B00EQ36838351-2C94152D-1848-4B53-9134-85A9ADC7A53FQ36978258-46E3A4AB-850A-49E4-9853-21586DE28C94Q37365588-B6BC850D-6898-49A3-AD3D-AB72CD4DE139Q37515272-B2205916-44CB-458C-A022-E53C3B34A971Q37599294-CE22B4A1-AA88-47A0-9B75-DD8DF36973BBQ37952437-40B98BDF-EC43-4F63-9630-5CB4648A9BD1Q38051207-73519E15-9A10-4FBB-A349-078E98561EF9Q38129760-71EB6E73-C46E-4AB3-A296-514D9C19A2BAQ38163432-C7A1849C-48F3-4CDD-9EDC-AB793BC31803Q38196736-73E7E391-CF23-434F-B6AA-AABAC67BF29CQ38232790-76F428D2-A360-4456-BE82-830B990C633FQ38267206-430D2316-3219-4311-B90E-A2F8849A59F5Q38524401-66A04A9F-60F1-49BF-99C7-1B39FCF6B47EQ38550227-13CE08CE-3A37-424C-A76D-753AFA30CF11Q39070560-E32F8455-C25E-4DA5-96C0-C6E4BC83CAFEQ42105623-5ED4609B-6733-4528-B57F-35C36120589AQ42641668-CFF942F5-1559-4069-9F71-E69E526382E2Q47112764-8F764E40-2076-4E15-9811-E5526527BB0CQ47263095-ADC669B7-CE8D-4EDF-9DCD-2DEBADD1C34BQ47759700-E53ADFD1-B650-463E-87A3-ECD5E1939EF6Q48822118-738AAFDB-53D8-4D32-9B5B-8343F9382899Q50886155-0F80A463-9CBC-4802-981C-27434C3CC104Q51287854-B7ED224C-3D29-4359-AC1F-303742296AB6Q51298854-D9C36EB8-E8BB-42E8-B7F3-E26446B9EB6DQ51325324-151D1951-C8D8-47C7-9667-3519A3E935FDQ53648464-81752752-AAC8-4A04-8A17-8FF96CCFD7A6
P2860
Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Laparoscopic Roux-en-Y gastric ...... with body mass index of 25-35
@ast
Laparoscopic Roux-en-Y gastric ...... with body mass index of 25-35
@en
type
label
Laparoscopic Roux-en-Y gastric ...... with body mass index of 25-35
@ast
Laparoscopic Roux-en-Y gastric ...... with body mass index of 25-35
@en
prefLabel
Laparoscopic Roux-en-Y gastric ...... with body mass index of 25-35
@ast
Laparoscopic Roux-en-Y gastric ...... with body mass index of 25-35
@en
P2093
P2860
P1433
P1476
Laparoscopic Roux-en-Y gastric ...... with body mass index of 25-35
@en
P2093
Chi-Hsien Lo
Chi-Ming Tai
Chih-Kun Huang
Jer-Yiing Houng
Yaw-Sen Chen
P2860
P2888
P304
P356
10.1007/S11695-011-0408-Z
P50
P577
2011-09-01T00:00:00Z